A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients - Investigational new drugs 2014 Oct 32-5 p1005-16
 
Assessing the necessity of including a crossover period with dual reporting when changing total prostate-specific antigen methods - Clinical Biochemistry 2014 Jul 47 - 10-11 p897-900


Vascular Endothelial Growth Factor Concentration as a Predictive Marker: Ready for Primetime? - Clinical Cancer Research 2010 Feb 16-4 p1341

Biochip arrays for the discovery of a biomarker surrogate in a phase I/II study assessing a novel anti-metastasis agent - Clinical Biochemistry 2009 Jul 42 - 10-11 p1162-5


 Cytokine elevations in acute coronary syndrome and ovarian cancer: A mechanism for the up-regulation of the acute phase proteins in these different disease etiologies - Clinical Biochemistry 2008 May 41 - 7-8 p607-10

Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis - Clinical Biochemistry 2007 Aug 40 - 12 p913-5


 Regulation of Smurf2 Ubiquitin Ligase Activity by Anchoring the E2 to the HECT Domain - Molecular Cell 2005 Aug 19 - 3 p297-308


TGF-β induces assembly of a Smad2–Smurf2 ubiquitin ligase complex that targets SnoN for degradation - Nature Cell Biology 2001 Jun 3 - 6 p587-95


Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFb Receptor for Degradation - Molecular Cell 2000 Dec 6 - 6 p1365-75

A SMAD-ubiquitin ligase targets theBMP pathway and affects embryonic pattern formation - Nature 1999 Aug 400 - 6745 p687-93

High-Sensitivity Troponin.com

Cancer Publications